Envoy Medical (COCH) Stock Forecast, Price Target & Predictions
COCH Stock Forecast
Envoy Medical stock forecast is as follows: an average price target of $6.00 (represents a 194.12% upside from COCH’s last price of $2.04) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
COCH Price Target
The average price target for Envoy Medical (COCH) is $6.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 194.12% upside from COCH's last price of $2.04.
COCH Analyst Ratings
According to 3 Wall Street analysts, Envoy Medical's rating consensus is 'Buy'. The analyst rating breakdown for COCH stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Envoy Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 03, 2024 | Frank Takkinen | Loop Capital Markets | $6.00 | $4.48 | 33.93% | 194.12% |
| Apr 03, 2024 | Frank Takkinen | Lake Street | $6.00 | $4.48 | 33.93% | 194.12% |
The latest Envoy Medical stock forecast, released on Apr 03, 2024 by Frank Takkinen from Loop Capital Markets, set a price target of $6.00, which represents a 33.93% increase from the stock price at the time of the forecast ($4.48), and a 194.12% increase from COCH last price ($2.04).
Envoy Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $6.00 |
| Last Closing Price | $2.04 | $2.04 | $2.04 |
| Upside/Downside | -100.00% | -100.00% | 194.12% |
In the current month, the average price target of Envoy Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Envoy Medical's last price of $2.04. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 19, 2024 | Brookline Capital | Buy | Buy | Hold |
| Jun 24, 2024 | Ascendiant | - | Buy | Initialise |
| Apr 03, 2024 | Lake Street | Buy | Buy | Hold |
Envoy Medical's last stock rating was published by Brookline Capital on Nov 19, 2024. The company gave COCH a "Buy" rating, the same as its previous rate.
Envoy Medical Financial Forecast
Envoy Medical Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $78.33K | $78.33K | $81.67K | $78.33K | $77.50K | $75.00K | $82.50K | $87.50K | $75.00K |
| High Forecast | $88.59K | $88.59K | $92.36K | $89.52K | $88.57K | $84.82K | $93.30K | $98.95K | $84.82K |
| Low Forecast | $68.90K | $68.90K | $71.83K | $67.14K | $66.43K | $65.97K | $72.57K | $76.96K | $65.97K |
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - |
Envoy Medical's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. COCH's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Envoy Medical EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-39.17K | $-39.17K | $-40.83K | $-39.17K | $-38.75K | $-37.50K | $-41.25K | $-43.75K | $-37.50K |
| High Forecast | $-34.45K | $-34.45K | $-35.92K | $-33.57K | $-33.21K | $-32.98K | $-36.28K | $-38.48K | $-32.98K |
| Low Forecast | $-44.29K | $-44.29K | $-46.18K | $-44.76K | $-44.28K | $-42.41K | $-46.65K | $-49.48K | $-42.41K |
| Surprise % | - | - | - | - | - | - | - | - | - |
undefined analysts predict COCH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Envoy Medical's previous annual EBITDA (undefined) of $NaN.
Envoy Medical Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-6.02M | $-6.02M | $-6.47M | $-7.32M | $-6.13M | $-5.35M | $-4.95M | $-4.41M | $-3.73M |
| High Forecast | $-5.07M | $-5.07M | $-5.46M | $-4.94M | $-4.75M | $-4.51M | $-4.18M | $-3.72M | $-3.14M |
| Low Forecast | $-7.04M | $-7.04M | $-7.58M | $-9.52M | $-7.71M | $-6.26M | $-5.80M | $-5.16M | $-4.36M |
| Surprise % | - | - | - | - | - | - | - | - | - |
Envoy Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. COCH's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Envoy Medical SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $1.02M | $1.02M | $1.06M | $1.02M | $1.01M | $973.43K | $1.07M | $1.14M | $973.43K |
| High Forecast | $1.15M | $1.15M | $1.20M | $1.16M | $1.15M | $1.10M | $1.21M | $1.28M | $1.10M |
| Low Forecast | $894.26K | $894.26K | $932.32K | $871.44K | $862.17K | $856.22K | $941.84K | $998.92K | $856.22K |
| Surprise % | - | - | - | - | - | - | - | - | - |
Envoy Medical's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to COCH last annual SG&A of $NaN (undefined).
Envoy Medical EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-0.31 | $-0.31 | $-0.33 | $-0.37 | $-0.31 | $-0.27 | $-0.25 | $-0.23 | $-0.19 |
| High Forecast | $-0.26 | $-0.26 | $-0.28 | $-0.25 | $-0.24 | $-0.23 | $-0.21 | $-0.19 | $-0.16 |
| Low Forecast | $-0.36 | $-0.36 | $-0.39 | $-0.49 | $-0.39 | $-0.32 | $-0.30 | $-0.26 | $-0.22 |
| Surprise % | - | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Envoy Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to COCH previous annual EPS of $NaN (undefined).